PERSPECTIVE THERAPEUTICS INC (CATX)

US46489V1044 - Common Stock

1.6  +0.07 (+4.58%)

After market: 1.61 +0.01 (+0.63%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-6-30)
2021
(2021-6-30)
2020
(2020-6-30)
2019
(2019-6-30)
Revenue
1.43M10.80M10.05M9.68M7.31M
Cost Of Goods
N/A6.18M4.93M4.56M4.27M
Gross Profit
N/A4.62M5.12M5.12M3.05M
Operating Expenses
42.38M12.01M8.56M8.60M8.32M
Research and Development
21.31M2.58M1.43M1.13M1.47M
Selling, General, and Administrative Expenses
21.06M9.43M7.13M7.55M6.85M
Operating Income
-40.94M-7.39M-3.44M-3.48M-5.27M
Interest Income/Expense
833.00K120.00K60.00K30.00K110.00K
Other Income/Expense
2.00KN/AN/A0.000.00
Non Recurring Items
0.000.00-10.00K0.0020.00K
Income Before Taxes
-40.11M-7.27M-3.39M-3.45M-5.14M
Income Tax
-2.65MN/AN/AN/AN/A
Net Income
-46.51M-7.27M-3.39M-3.46M-5.16M
EBITDA
-39.95M-7.10M-3.25M-3.29M-5.08M
 
Per Share Data
EPS Diluted Total Ops
-0.17-0.05-0.03-0.05-0.08
Non GAAP EPS
N/A-0.05-0.04-0.05-0.08
 
Statistics
Gross Profit Margin
N/A42.78%50.95%52.89%41.72%
Profit Margin
-3243.24%-67.31%-33.73%-35.74%-70.59%
Operating Profit Margin
-2855.02%-68.43%-34.23%-35.95%-72.09%

All data in USD

Charts